Logistic regression analyses of factors that predict primary care providers’ willingness to continue hormone therapy for transgender patients (2015)
| Variables . | AOR . | 95% CI . | P-Value . |
|---|---|---|---|
| Race | |||
| White (ref) | 1.00 | ||
| Black | 2.482 | 0.479–12.850 | 0.279 |
| Asian | 0.556 | 0.143–2.153 | 0.395 |
| Other | 1.087 | 0.307–3.854 | 0.897 |
| Religion | |||
| Christian (ref) | 1.00 | ||
| Atheist | 0.410 | 0.101–1.660 | 0.212 |
| Jewish | 12.105 | 1.078–135.95 | 0.043 |
| Muslim | 0.856 | 0.230–3.186 | 0.816 |
| Hindu | 0.375 | 0.083–1.701 | 0.204 |
| Other | 0.137 | 0.021–.882 | 0.036 |
| Provider type | |||
| Resident (ref) | 1.00 | ||
| Advanced practitioner | 0.198 | 0.016–2.467 | 0.208 |
| Attending physician | 0.220 | 0.089–0.546 | 0.001 |
| Ever met transgender person | 2.259 | 0.759–6.722 | 0.143 |
| Ever continued hormone therapy | 3.643 | 0.912–14.54 | 0.067 |
| Transphobia score | 0.679 | 0.441–1.045 | 0.078 |
| Capable of providing routine care to transgender patients | 2.447 | 1.006–5.953 | 0.049 |
| Familiar with any HT regimen | 2.217 | 0.596–8.246 | 0.235 |
| Variables . | AOR . | 95% CI . | P-Value . |
|---|---|---|---|
| Race | |||
| White (ref) | 1.00 | ||
| Black | 2.482 | 0.479–12.850 | 0.279 |
| Asian | 0.556 | 0.143–2.153 | 0.395 |
| Other | 1.087 | 0.307–3.854 | 0.897 |
| Religion | |||
| Christian (ref) | 1.00 | ||
| Atheist | 0.410 | 0.101–1.660 | 0.212 |
| Jewish | 12.105 | 1.078–135.95 | 0.043 |
| Muslim | 0.856 | 0.230–3.186 | 0.816 |
| Hindu | 0.375 | 0.083–1.701 | 0.204 |
| Other | 0.137 | 0.021–.882 | 0.036 |
| Provider type | |||
| Resident (ref) | 1.00 | ||
| Advanced practitioner | 0.198 | 0.016–2.467 | 0.208 |
| Attending physician | 0.220 | 0.089–0.546 | 0.001 |
| Ever met transgender person | 2.259 | 0.759–6.722 | 0.143 |
| Ever continued hormone therapy | 3.643 | 0.912–14.54 | 0.067 |
| Transphobia score | 0.679 | 0.441–1.045 | 0.078 |
| Capable of providing routine care to transgender patients | 2.447 | 1.006–5.953 | 0.049 |
| Familiar with any HT regimen | 2.217 | 0.596–8.246 | 0.235 |
χ2 = 45.637, P < 0.001, R2 = 0.367.
Logistic regression analyses of factors that predict primary care providers’ willingness to continue hormone therapy for transgender patients (2015)
| Variables . | AOR . | 95% CI . | P-Value . |
|---|---|---|---|
| Race | |||
| White (ref) | 1.00 | ||
| Black | 2.482 | 0.479–12.850 | 0.279 |
| Asian | 0.556 | 0.143–2.153 | 0.395 |
| Other | 1.087 | 0.307–3.854 | 0.897 |
| Religion | |||
| Christian (ref) | 1.00 | ||
| Atheist | 0.410 | 0.101–1.660 | 0.212 |
| Jewish | 12.105 | 1.078–135.95 | 0.043 |
| Muslim | 0.856 | 0.230–3.186 | 0.816 |
| Hindu | 0.375 | 0.083–1.701 | 0.204 |
| Other | 0.137 | 0.021–.882 | 0.036 |
| Provider type | |||
| Resident (ref) | 1.00 | ||
| Advanced practitioner | 0.198 | 0.016–2.467 | 0.208 |
| Attending physician | 0.220 | 0.089–0.546 | 0.001 |
| Ever met transgender person | 2.259 | 0.759–6.722 | 0.143 |
| Ever continued hormone therapy | 3.643 | 0.912–14.54 | 0.067 |
| Transphobia score | 0.679 | 0.441–1.045 | 0.078 |
| Capable of providing routine care to transgender patients | 2.447 | 1.006–5.953 | 0.049 |
| Familiar with any HT regimen | 2.217 | 0.596–8.246 | 0.235 |
| Variables . | AOR . | 95% CI . | P-Value . |
|---|---|---|---|
| Race | |||
| White (ref) | 1.00 | ||
| Black | 2.482 | 0.479–12.850 | 0.279 |
| Asian | 0.556 | 0.143–2.153 | 0.395 |
| Other | 1.087 | 0.307–3.854 | 0.897 |
| Religion | |||
| Christian (ref) | 1.00 | ||
| Atheist | 0.410 | 0.101–1.660 | 0.212 |
| Jewish | 12.105 | 1.078–135.95 | 0.043 |
| Muslim | 0.856 | 0.230–3.186 | 0.816 |
| Hindu | 0.375 | 0.083–1.701 | 0.204 |
| Other | 0.137 | 0.021–.882 | 0.036 |
| Provider type | |||
| Resident (ref) | 1.00 | ||
| Advanced practitioner | 0.198 | 0.016–2.467 | 0.208 |
| Attending physician | 0.220 | 0.089–0.546 | 0.001 |
| Ever met transgender person | 2.259 | 0.759–6.722 | 0.143 |
| Ever continued hormone therapy | 3.643 | 0.912–14.54 | 0.067 |
| Transphobia score | 0.679 | 0.441–1.045 | 0.078 |
| Capable of providing routine care to transgender patients | 2.447 | 1.006–5.953 | 0.049 |
| Familiar with any HT regimen | 2.217 | 0.596–8.246 | 0.235 |
χ2 = 45.637, P < 0.001, R2 = 0.367.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
